Selected research
Market Structure
Global Stem Cell Therapy for Osteoarthritis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Stem Cell Therapy for Osteoarthritis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Stem Cell Therapy for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Stem Cell Therapy for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Stem Cell Therapy for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Stem Cell Therapy for Osteoarthritis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Stem Cell Therapy for Osteoarthritis include Xintela AB, UCI Health, Theracell Advanced Biotechnology, Stempeutics, Regeneus, Nature Cell, Medipost, Magellan and CellTex Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Stem Cell Therapy for Osteoarthritis market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Stem Cell Therapy for Osteoarthritis and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Stem Cell Therapy for Osteoarthritis revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Stem Cell Therapy for Osteoarthritis market size, projected growth trends, production technologies, key applications, and end-use industries.
Stem Cell Therapy for Osteoarthritis Segment by Company
Xintela AB
UCI Health
Theracell Advanced Biotechnology
Stempeutics
Regeneus
Nature Cell
Medipost
Magellan
CellTex Therapeutics
Cells for Cells
AbelZeta Pharma
Stem Cell Therapy for Osteoarthritis Segment by Type
Fat Cell
Bone Marrow Cell
Others
Stem Cell Therapy for Osteoarthritis Segment by Application
Primary Osteoarthritis
Secondary Osteoarthritis
Stem Cell Therapy for Osteoarthritis Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Therapy for Osteoarthritis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Therapy for Osteoarthritis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Therapy for Osteoarthritis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Stem Cell Therapy for Osteoarthritis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Stem Cell Therapy for Osteoarthritis industry.
Chapter 3: Detailed analysis of Stem Cell Therapy for Osteoarthritis companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cell Therapy for Osteoarthritisrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fat Cell
- Bone Marrow Cell
- Others
Applications
- Primary Osteoarthritis
- Secondary Osteoarthritis
Companies covered
- Xintela AB
- UCI Health
- Theracell Advanced Biotechnology
- Stempeutics
- Regeneus
- Nature Cell
- Medipost
- Magellan
- CellTex Therapeutics
- Cells for Cells
- AbelZeta Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Fat Cell
- 1.2.3 Bone Marrow Cell
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Primary Osteoarthritis
- 1.3.3 Secondary Osteoarthritis
- 1.4 Global Market Growth Prospects
- 1.5 Global Stem Cell Therapy for Osteoarthritis Growth Trends by Region
- 1.5.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Stem Cell Therapy for Osteoarthritis Market Size by Region (2021-2026)
- 1.5.3 Stem Cell Therapy for Osteoarthritis Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Stem Cell Therapy for Osteoarthritis Market Dynamics
- 2.1 Stem Cell Therapy for Osteoarthritis Industry Trends
- 2.2 Stem Cell Therapy for Osteoarthritis Industry Drivers
- 2.3 Stem Cell Therapy for Osteoarthritis Industry Opportunities and Challenges
- 2.4 Stem Cell Therapy for Osteoarthritis Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Stem Cell Therapy for Osteoarthritis Revenue by Company (2021-2026)
- 3.2 Global Stem Cell Therapy for Osteoarthritis Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Stem Cell Therapy for Osteoarthritis Key Company Head office and Area Served
- 3.4 Global Stem Cell Therapy for Osteoarthritis Company, Product Type & Application
- 3.5 Global Stem Cell Therapy for Osteoarthritis Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Stem Cell Therapy for Osteoarthritis Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Stem Cell Therapy for Osteoarthritis Players Market Share by Revenue in 2025
- 3.6.3 2025 Stem Cell Therapy for Osteoarthritis Tier 1, Tier 2, and Tier 3
4 Stem Cell Therapy for Osteoarthritis Market by Type
- 4.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Stem Cell Therapy for Osteoarthritis Market Size by Type (2021-2032)
- 4.3 Global Stem Cell Therapy for Osteoarthritis Market Size Share by Type (2021-2032)
5 Stem Cell Therapy for Osteoarthritis Market by Application
- 5.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Stem Cell Therapy for Osteoarthritis Market Size by Application (2021-2032)
- 5.3 Global Stem Cell Therapy for Osteoarthritis Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Xintela AB
- 6.1.1 Xintela AB Company Information
- 6.1.2 Xintela AB Business Overview
- 6.1.3 Xintela AB Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Xintela AB Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.1.5 Xintela AB Recent Developments
- 6.2 UCI Health
- 6.2.1 UCI Health Company Information
- 6.2.2 UCI Health Business Overview
- 6.2.3 UCI Health Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 UCI Health Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.2.5 UCI Health Recent Developments
- 6.3 Theracell Advanced Biotechnology
- 6.3.1 Theracell Advanced Biotechnology Company Information
- 6.3.2 Theracell Advanced Biotechnology Business Overview
- 6.3.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.3.5 Theracell Advanced Biotechnology Recent Developments
- 6.4 Stempeutics
- 6.4.1 Stempeutics Company Information
- 6.4.2 Stempeutics Business Overview
- 6.4.3 Stempeutics Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Stempeutics Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.4.5 Stempeutics Recent Developments
- 6.5 Regeneus
- 6.5.1 Regeneus Company Information
- 6.5.2 Regeneus Business Overview
- 6.5.3 Regeneus Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Regeneus Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.5.5 Regeneus Recent Developments
- 6.6 Nature Cell
- 6.6.1 Nature Cell Company Information
- 6.6.2 Nature Cell Business Overview
- 6.6.3 Nature Cell Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Nature Cell Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.6.5 Nature Cell Recent Developments
- 6.7 Medipost
- 6.7.1 Medipost Company Information
- 6.7.2 Medipost Business Overview
- 6.7.3 Medipost Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Medipost Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.7.5 Medipost Recent Developments
- 6.8 Magellan
- 6.8.1 Magellan Company Information
- 6.8.2 Magellan Business Overview
- 6.8.3 Magellan Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Magellan Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.8.5 Magellan Recent Developments
- 6.9 CellTex Therapeutics
- 6.9.1 CellTex Therapeutics Company Information
- 6.9.2 CellTex Therapeutics Business Overview
- 6.9.3 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.9.5 CellTex Therapeutics Recent Developments
- 6.10 Cells for Cells
- 6.10.1 Cells for Cells Company Information
- 6.10.2 Cells for Cells Business Overview
- 6.10.3 Cells for Cells Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Cells for Cells Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.10.5 Cells for Cells Recent Developments
- 6.11 AbelZeta Pharma
- 6.11.1 AbelZeta Pharma Company Information
- 6.11.2 AbelZeta Pharma Business Overview
- 6.11.3 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Product Portfolio
- 6.11.5 AbelZeta Pharma Recent Developments
7 North America
- 7.1 North America Stem Cell Therapy for Osteoarthritis Market Size (2021-2032)
- 7.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type
- 7.2.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2021-2026)
- 7.2.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2027-2032)
- 7.2.3 North America Stem Cell Therapy for Osteoarthritis Market Share by Type (2021-2032)
- 7.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Application
- 7.3.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2021-2026)
- 7.3.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2027-2032)
- 7.3.3 North America Stem Cell Therapy for Osteoarthritis Market Share by Application (2021-2032)
- 7.4 North America Stem Cell Therapy for Osteoarthritis Market Size by Country
- 7.4.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2021-2026)
- 7.4.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2027-2032)
- 7.4.4 North America Stem Cell Therapy for Osteoarthritis Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Stem Cell Therapy for Osteoarthritis Market Size (2021-2032)
- 8.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type
- 8.2.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2021-2026)
- 8.2.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2027-2032)
- 8.2.3 Europe Stem Cell Therapy for Osteoarthritis Market Share by Type (2021-2032)
- 8.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application
- 8.3.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2021-2026)
- 8.3.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2027-2032)
- 8.3.3 Europe Stem Cell Therapy for Osteoarthritis Market Share by Application (2021-2032)
- 8.4 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country
- 8.4.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2021-2026)
- 8.4.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2027-2032)
- 8.4.4 Europe Stem Cell Therapy for Osteoarthritis Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Stem Cell Therapy for Osteoarthritis Market Size (2021-2032)
- 9.2 China Stem Cell Therapy for Osteoarthritis Market Size by Type
- 9.2.1 China Stem Cell Therapy for Osteoarthritis Market Size by Type (2021-2026)
- 9.2.2 China Stem Cell Therapy for Osteoarthritis Market Size by Type (2027-2032)
- 9.2.3 China Stem Cell Therapy for Osteoarthritis Market Share by Type (2021-2032)
- 9.3 China Stem Cell Therapy for Osteoarthritis Market Size by Application
- 9.3.1 China Stem Cell Therapy for Osteoarthritis Market Size by Application (2021-2026)
- 9.3.2 China Stem Cell Therapy for Osteoarthritis Market Size by Application (2027-2032)
- 9.3.3 China Stem Cell Therapy for Osteoarthritis Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Stem Cell Therapy for Osteoarthritis Market Size (2021-2032)
- 10.2 Asia Stem Cell Therapy for Osteoarthritis Market Size by Type
- 10.2.1 Asia Stem Cell Therapy for Osteoarthritis Market Size by Type (2021-2026)
- 10.2.2 Asia Stem Cell Therapy for Osteoarthritis Market Size by Type (2027-2032)
- 10.2.3 Asia Stem Cell Therapy for Osteoarthritis Market Share by Type (2021-2032)
- 10.3 Asia Stem Cell Therapy for Osteoarthritis Market Size by Application
- 10.3.1 Asia Stem Cell Therapy for Osteoarthritis Market Size by Application (2021-2026)
- 10.3.2 Asia Stem Cell Therapy for Osteoarthritis Market Size by Application (2027-2032)
- 10.3.3 Asia Stem Cell Therapy for Osteoarthritis Market Share by Application (2021-2032)
- 10.4 Asia Stem Cell Therapy for Osteoarthritis Market Size by Country
- 10.4.1 Asia Stem Cell Therapy for Osteoarthritis Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Stem Cell Therapy for Osteoarthritis Market Size by Country (2021-2026)
- 10.4.3 Asia Stem Cell Therapy for Osteoarthritis Market Size by Country (2027-2032)
- 10.4.4 Asia Stem Cell Therapy for Osteoarthritis Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type
- 11.2.1 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application
- 11.3.1 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country
- 11.4.1 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst